| | |

COVID-19 in Mesothelioma Patients: Case Highlights Unusual Symptoms

COVID-19 in Mesothelioma Patients

There’s evidence that the symptoms of COVID-19 in mesothelioma patients may sometimes be different than in other people. 

Pakistani doctors say one of their mesothelioma patients developed stomach distension as a result of the coronavirus. The man also complained of severe abdominal pain.

The case highlights the need for doctors and patients to watch for unusual symptoms of COVID-19 in mesothelioma patients.

The Danger of Coronavirus for Asbestos Cancer Patients

SARS-CoV2 is the coronavirus that causes COVID-19. In most symptomatic people, COVID-19 causes respiratory symptoms. Some people just get the sniffles while others develop severe breathing problems. 

People with pleural mesothelioma may be at special risk from the virus. Their lungs are already compromised by the cancer. Breathing problems are common with mesothelioma.

COVID-19 in mesothelioma patients may also be a problem because of compromised immunity. Mesothelioma treatments like chemotherapy and immunotherapy may make it harder for the body to fight a virus. 

Finally, COVID-19 seems to hit seniors especially hard. Most mesothelioma cases occur in people over 70.  One study found that more than half of lung cancer patients who get COVID-19 die of it. It is not surprising that many patients put off their mesothelioma treatment during the pandemic to avoid infection.

Understanding COVID-19 in Mesothelioma Patients

But the new case study shows COVID-19 in mesothelioma patients may not behave as expected. In the title of the article, the authors ask, “Do We Need to Think Outside the Box?”

That is because their patient was unusual in several ways. The man was just 46 years old and had advanced pleural mesothelioma. He was on chemotherapy to help with his mesothelioma symptoms

The patient came to the hospital with a painful swollen stomach but no respiratory problems. COVID-19 in mesothelioma patients can be serious, so doctors tested him just in case. They were surprised to get a positive result.

“The patient presented with no signs of respiratory compromise despite his cancer status,” writes author Muhammad Irfan. “Further confounding this presentation was the presence of his acute abdominal symptoms.”

Gastrointestinal symptoms of COVID-19 in mesothelioma patients are very rare. The authors say larger studies might help doctors understand what causes them. In the meantime, Dr. Irfan and his colleagues say mesothelioma doctors should not rule out coronavirus just because the symptoms are unusual.

“Physicians should therefore remain cognizant of the possibility of gastrointestinal symptoms secondary to a COVID-19 infection even in the absence of respiratory symptoms,” they write.

Sources:

Irfan, M, et al, “Coronavirus Disease 2019 Presenting as Abdominal Distension in a Mesothelioma Patient: Do We Need to Think Outside the Box?”, August 22, 2020, Cureus, Case Reports, https://www.cureus.com/articles/40063

Rogado J, Pangua C, Serrano-Montero G, et al.: Covid-19 and lung cancer: a greater fatality rate?. Lung Cancer. 2020, 146:19-22, https://linkinghub.elsevier.com/retrieve/pii/S0169500220304682

Similar Posts

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…

  • | |

    Spanish Mesothelioma Deaths Likely to Continue for Decades

    New research in Spain suggests that mesothelioma deaths will continue in the country until the “last surviving member” of the group of people exposed to occupational asbestos succumbs to the disease. Like many countries, Spain used asbestos heavily in the first half of the 20th century, especially in construction, where the mineral was prized for its durability, low cost, and resistance to fire and corrosion.  Asbestos was banned in Spain in 2002. Observing that more than 2.5 million metric tons of asbestos were imported into Spain from 1906 to 2002, researchers say deaths from mesothelioma have risen steadily. Between 1976 and 1980, a total of 491 Spanish people died of mesothelioma. By the 5-year period from 2006 to 2010, that…

  • | |

    Micro-RNAs May Offer New Way to Fight Mesothelioma

    Scientists at one of the world’s top mesothelioma research centers, the Asbestos Diseases Research institute in Sydney, Australia, say that restoring the expression of certain micro RNAs in the cells of mesothelioma patients may offer a new way to fight the disease. A microRNA is a small RNA molecule which is involved in the regulation of gene expression. According to a new report in the Annals of Oncology, the Australian scientists found reduced expression of the micro RNA-15 family (miR-15/16) in the cells of mice with mesothelioma. “When malignant pleural mesothelioma cell lines were compared with the normal mesothelial cell line MeT-5A, the downregulation of miR-15/16 was 2- to 10-fold,” they report. This finding is consistent with previous cancer research…